Broyhill Views Avantor (AVTR) as a Costly Mistake. Here’s Why

In its fourth-quarter 2025 capitalist letter, Broyhill Asset Management highlighted stocks similar Avantor, Inc. (NYSE:AVTR). Headquartered successful Radnor, Pennsylvania, Avantor, Inc. (NYSE:AVTR) provides mission-critical products and services to biotechnology, education, and pharmaceutical companies. On February 25, 2026, Avantor, Inc. (NYSE:AVTR) banal closed astatine $9.06 per share. One-month instrumentality of Avantor, Inc. (NYSE:AVTR) was -16.19%, and its shares mislaid 45.06% implicit the past 52 weeks. Avantor, Inc. (NYSE:AVTR) has a marketplace capitalization of $6.18 billion.

Broyhill Asset Management stated the pursuing regarding Avantor, Inc. (NYSE:AVTR) successful its 4th fourth 2025 capitalist letter:

"Our mistakes were costly. Our largest detractors were Avantor, Inc. (NYSE:AVTR), Fiserv, and Six Flags. Losers besides shared a communal thread: fiscal leverage amplified by execution missteps. Avantor was our biggest detractor from show connected the year. When we initiated the position, we underwrote a classical betterment setup: orders bottom, gradually recover, and net inflect. While this rhythm has played retired longer than we initially expected, with uncertainty magnified by unpredictable authorities policy, the manufacture upturn has go progressively hard to ignore. The contented for Avantor has been that a cyclical downturn morphed into competitory and operational challenges, with company-specific execution masking the manufacture upturn. Consequently, we chopped the presumption successful fractional aft the institution announced absorption changes and second-quarter results that again fell abbreviated of our expectations, and reinvested the proceeds into Thermo Fisher, the superior beneficiary of Avantor’s challenges. We proceed to support our reduced presumption successful the institution arsenic we presumption AVTR arsenic a uncommon strategical plus with aggregate self-help levers, with the enactment of a strategical merchantability should those levers neglect to impressment precocious engaged activists. In the meantime, the radical remains under-owned with important superior connected the sidelines inactive looking for an introduction point, portion revenues are reaccelerating, reshoring investments are acceptable to supply incremental upside, and caller agreements betwixt large pharma and the existent medication person removed overmuch of the downside hazard associated with argumentation headwinds."